Maven Securities’s bluebird bio BLUE Stock Holding History

Maven Securities’s Portfolio BLUE Stock Details BLUE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-12,500	Closed	-$795K	–	876
2023 Q1	$795K	Buy	+12,500	New	+$1.43M	0.02%	523
2020 Q3	–	Sell	-15,440	Closed	-$12.2M	–	616
2020 Q2	$12.2M	Buy	+15,440	New	+$11.6M	0.84%	21
2020 Q1	–	Sell	-4,421	Closed	-$5.07M	–	325
2019 Q4	$5.07M	Buy	+4,421	New	+$4.81M	0.46%	40
2018 Q2	–	Sell	-232	Closed	-$512K	–	69
2018 Q1	$512K	Buy	+232	New	+$590K	0.27%	58

Other funds holding BLUE

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

TCM

Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return

PHS

PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

GIM

Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return

PAMS

Pictet Asset Management (Switzerland) Geneva 73, Switzerland $84.3B AUM 26.5% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return

Maven Securities's BLUE Position: Q2 2023 in Review

Maven Securities sold out of bluebird bio (BLUE) in Q2 2023, closing a stake of 12,500 shares — an estimated $795K sold.

Maven Securities first reported a position in BLUE in Q1 2018 and held it in 4 quarters. The position peaked at $12.2M in Q2 2020. 175 funds tracked by Wall St. Rank hold BLUE as of Q2 2023.

Maven Securities reported no remaining bluebird bio position as of Q2 2023 after selling out during the quarter.
Maven Securities sold 12,500 bluebird bio shares in Q2 2023, an estimated $795K.
Maven Securities first reported a position in bluebird bio in Q1 2018 and held it in 4 quarters.
Maven Securities's bluebird bio position peaked at $12.2M in Q2 2020.
175 funds tracked by Wall St. Rank held bluebird bio as of Q2 2023.

Based on Maven Securities's 13F filing for Q2 2023, filed 4 Aug 2023.